Connect with us

Hi, what are you looking for?

Jewish Business News


Perrigo falls after rejecting improved Mylan offer

Joseph C. Papa - PERRIGO - PR
Both Perrigo and Teva are down on the Tel Aviv Stock Exchange following the Independence Day break.

After US-Israeli pharmaceuticals company Perrigo (PRGO) rejected Mylan’s (MYL) takeover bid last Tuesday, on Friday, Mylan announced an improved offer worth $31.8 billion. The original offer was $29 billion, or $205 per share.

Mylan is new offering $60 cash and 2.2 of its shares for each Perrigo share, valuing Perrigo shares at about $222 each.



  GLOBES logo-eng (1)Published by Globes [online], Israel business news –




You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.